Arthur Y-Shin Kim, MD

Dr. Kim earned his MD from Harvard Medical School. After his internship and residency at Massachusetts General Hospital and fellowship in Infectious Diseases at MGH and Harvard Medical School, he joined the faculty at Harvard where he is currently Associate Professor of Medicine.
Dr. Kim is the Director of the Viral Hepatitis Clinic within the Division of Infectious Diseases at MGH and focuses his clinical and research interests on special populations with HCV, including those with HIV-1/HCV coinfection and in people who inject drugs. He recently completed a 3 year term as co-chair of the AASLD / IDSA Guidance Panel for Recommendations for Testing, Managing, and Treating Hepatitis C (available at hcvguidelines.org). He is a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Since the pandemic, he has been leading institutional guidance for treatment of COVID-19 at MGH, is co-author of the UpToDate chapter regarding the care of hospitalized patients with COVID-19, and is a member of the NIH COVID-19 Treatment Guidelines Panel.